Exhibit 99.1

Herbalife Ltd. Announces Record Fourth Quarter Revenue and EPS and Raises FY’10 EPS Guidance

LOS ANGELES--(BUSINESS WIRE)--February 23, 2010--Herbalife Ltd. (NYSE:HLF) today reported fourth quarter net sales increased 23.0 percent to $630.9 million and local currency net sales increased 15.8 percent compared to the same period in 2008. For the quarter ended December 31, 2009, the company reported net income of $55.7 million, or $0.88 per diluted share compared to $33.7 million or $0.53 per diluted share in the fourth quarter of 2008, reflecting local currency sales growth, operating margin expansion, a lower effective tax rate and accretion from the share repurchase program.

Excluding the Venezuela currency impact and other adjusting items in the fourth quarter 2009 and 2008 1, fourth quarter adjusted net income was $61.7 million, or $0.98 in adjusted diluted earnings per share, reflecting an increase of 42.3 percent and 42.0 percent, respectively, compared to the same period in 2008.

For the twelve months ended December 31, 2009, the company reported net sales of $2.3 billion, a 1.5 percent decline primarily due to the negative impact of foreign currency fluctuations whereas in local currency net sales for fiscal 2009 increased 5.1 percent compared to fiscal 2008. For the year ended December 31, 2009, the company reported net income of $203.3 million, or $3.22 per diluted share, compared to $221.2 million, or $3.36 per diluted share for the year ended December 31, 2008. Excluding the impact from adjusting items in both periods 1, adjusted net income was $207.1 million, or $3.28 in adjusted diluted earnings per share, a decrease of 10.8 percent and 7.1 percent respectively, compared to 2008 primarily due to the negative impact of foreign currency fluctuations and a higher effective tax rate in 2008.

For the twelve months ended December 31, 2009, the company generated cash flow from operations of $285.1 million, an increase of 4.4 percent compared to 2008, paid dividends of $48.7 million, invested $60.1 million in capital expenditures, repurchased $74.6 million in common stock and paid approximately $10.0 million for certain acquired manufacturing assets. The company’s net debt balance at the end of the fourth quarter was $99.5 million, reflecting an improvement of $101.3 million from December 2008.


“We are proud that despite the difficult economic climate of 2009, we were able to achieve record local-currency sales results, and we are excited about our positive momentum going into 2010. Our distributors’ adoption of the daily-consumption method of doing business creates deeper reach into existing markets and is fueling the growth of the company,” said Chairman and Chief Executive Officer Michael O. Johnson. “The Herbalife opportunity addresses two of the largest global challenges facing society today; health and a source of income. We will continue to provide the best nutrition products with proven ingredients, and to provide the tools our Distributors need to build their businesses.”

Business Highlights

During the fourth quarter the company hosted three Extravaganzas,in Nanjing, China, Johannesburg, South Africa and Atlanta, Georgia which collectively were attended by more than 25,000 participants.

For the year ended December 31, 2009, our top ten products accounted for 73.1 percent of the company’s total volume points, a 3.5 percent increase compared to 2008. The company’s top three products, those used most within nutrition clubs, Formula 1, Herbal Tea concentrate and Aloe concentrate, accounted for 50.8 percent of volume points, compared to 49.4 percent in the prior year. For the year ended December 31, 2009, volume points of those three products collectively increased 5.2 percent compared to 2008.

During the quarter the company opened two new markets, Vietnam and Paraguay.

2009 Annual Sales Leader Requalification

By January of each year, sales leaders are required to re-qualify. In February of each year, we remove from the rank of sales leaders those individuals who did not satisfy the sales leader qualification requirements during the preceding 12 months. For the latest 12-month requalification period ending January 2010, approximately 43.0 percent of the eligible sales leaders requalified, reflecting an improvement from 40.3 percent in 2008.


Fourth Quarter and Full Year 2009 Regional Key Metrics 2

                         
Region   4Q'09     4Q'09   FY'09   4Q'09   FY'09
Volume Avg Active Avg Active New Sales New Sales
Points % Chg Sales Leader Sales Leader Leaders Leaders
    (Mil)   (Y/Y)   % Chg (Y/Y)   % Chg (Y/Y)   % Chg (Y/Y)   % Chg (Y/Y)
North America 185.3 12.8 % 11.5 % 6.1 % (5.2 %) (12.1 %)
Asia Pacific 152.1 34.4 % 19.5 % 11.6 % 44.0 % 26.9 %
EMEA 115.5 0.6 % 1.4 % (2.3 %) (24.3 %) (19.9 %)
Mexico 122.4 8.4 % 2.4 % (6.6 %) 18.7 % (16.2 %)
South & Central America 109.2 10.2 % 6.2 % 2.8 % (21.8 %) (36.0 %)
China   29.4   (6.8 %)   (4.7 %)   2.7 %   (19.8 %)   (12.4 %)
Total   713.9   12.3 %   7.4 %   1.9 %   0.2 %   (11.2 %)
 

The North America region reported volume points of 185.3 million in the fourth quarter of 2009, reflecting an increase of 12.8 percent versus the same period of 2008. Volume point growth in the U.S., the largest country in the region, increased 13.8 percent compared to 2008, reflecting an increase in the Latin market of 22.1 percent and a decrease in the general market of 0.2 percent compared to the fourth quarter of 2008.

During the quarter and for the full year, New Sales Leaders in the region decreased 5.2 percent and 12.1 percent respectively versus the same periods of 2008. Average Active Sales Leaders in North America accelerated over the course of the year. For 2009, Average Active Sales Leaders increased 6.1 percent compared to the prior year and for the quarter ended December 31, 2009, Average Active Sales Leaders increased 11.5 percent.

The Asia Pacific region reported volume points of 152.1 million in the fourth quarter of 2009, reflecting an increase of 34.4 percent over the same period of 2008. Top markets in this region were Taiwan, with volume point growth of 19.7 percent; Korea, with volume point growth of 95.8 percent; and Malaysia, with volume point growth of 15.4 percent, all compared to the same period in 2008. For the quarter ended December 31, 2009 New Sales Leaders in the region increased 44.0 percent versus the same period last year. Average Active Sales Leaders in the quarter improved 19.5 percent and for the year ended December 31, 2009 improved 11.6 percent compared to comparable periods in 2008.

The Europe, Middle East and Africa (EMEA) region reported volume points of 115.5 million in the fourth quarter of 2009, reflecting an increase of 0.6 percent versus the same period of 2008. The top markets in this region were Italy and Russia, with volume point growth of 13.0 percent and a decline of 7.1 percent, respectively, compared to the same period in 2008. New Sales Leaders declined 24.3 percent for the quarter ended December 31, 2009 versus the same period last year. While Average Active Sales Leaders in EMEA decreased 2.3 percent for the year compared to 2008, Average Activity in the region during the fourth quarter increased 1.4 percent, the first period of positive Activity growth since early 2007.


The Mexico region reported volume points of 122.4 million in the fourth quarter of 2009, reflecting an increase of 8.4 percent versus the same period of 2008. Fourth quarter 2009 was the first full quarter in which the company anniversaried the collection of the 15 percent Value Added Tax (VAT) which had a negative impact on our financial results. New Sales Leaders for 2009 declined 16.2 percent, but for the quarter ended December 31, 2009, New Sales Leaders increased 18.7 percent compared to the same period last year. While Average Active Sales Leaders in Mexico decreased 6.6 percent for the year, fourth quarter Activity increased 2.4 percent; the first positive quarter since mid 2008.

The South and Central America region reported volume points of 109.2 million in the fourth quarter of 2009, reflecting an increase of 10.2 percent versus the same period of 2008. During the fourth quarter, the top markets in this region were Brazil, with volume point growth of 12.2 percent, and Venezuela, with a volume point increase of 24.1 percent, both compared to the same period in 2008. New Sales Leaders in the region were 21.8 percent lower during the quarter ended December 31, 2009 than the same period last year. Average Active Sales Leaders improved 6.2 percent for the quarter and full year 2009 average activity increased 2.8 percent compared to 2008.

The China region reported volume points of 29.4 million in the fourth quarter of 2009, reflecting a decrease of 6.8 percent over the same period of 2008. The company is currently licensed for direct sales in 11 provinces. New Sales Leaders in China decreased 19.8 percent during the quarter ended December 31, 2009 versus the same period last year. While Average Active Sales Leaders declined 4.7 percent for the quarter, Average Activity for the year increased 2.7 percent compared to 2008.


2010 Guidance

Based on current business trends, the company’s first quarter 2010 and fiscal 2010 guidance is provided below.

Effective January 1, 2010, Venezuela has been designated as a highly inflationary economy. Our 2010 guidance excludes the impact of a one-time charge related to highly inflationary accounting for Venezuela. However, included in our 2010 guidance is the assumption of applying the parallel market exchange rate and highly inflationary accounting for Venezuela during 2010. While, as previously disclosed, the move to highly inflationary accounting causes no material change to our EPS guidance, this change will negatively impact net sales guidance. 3, 4

First Quarter - The company’s first quarter 2010 diluted earnings per share guidance range is $0.77 to $0.80 5 on volume point growth of 3.0 percent to 4.0 percent and net sales growth of 12.5 percent to 13.5 percent compared to the same period in 2009 3, respectively, and an effective tax rate range of 30.0 percent to 31.0 percent. The company’s first quarter 2010 capital expenditures are expected to be in the range of $15 million to $20 million.

Fiscal 2010 - The company’s new full-year diluted earnings per share guidance is $3.58 to $3.70 5 on volume point growth of 5.0 percent to 6.0 percent and a net sales increase of 8.5 percent to 9.5 percent compared to 2009 4, respectively, along with an effective tax rate range of 30.0 to 31.0 percent. Full-year 2010 capital expenditures are expected to be in the range of $65 million to $75 million.

Fourth Quarter Earnings Conference Call

Herbalife's senior-management team will host an investor conference call to discuss the company’s fourth quarter 2009 financial results and provide an update on current business trends on Wednesday, February 24 at 8 a.m. PST (11 a.m. EST).

The dial-in number for this conference call for domestic callers is (877) 758-1051 and (706) 634-5671 for international callers (conference ID 51796805). Live audio of the conference call will be simultaneously webcast in the investor relations section of the company's Web site at http://ir.herbalife.com.

An audio replay will be available following the completion of the conference call in MP3 format or by dialing (800) 642-1687 for domestic callers or (706) 645-9291 for international callers (conference ID 51796805). The webcast of the teleconference will be archived and available on Herbalife's Web site.


About Herbalife Ltd.

Herbalife Ltd. (NYSE:HLF) is a global network marketing company that sells weight-management, nutrition, and personal care products intended to support a healthy lifestyle. Herbalife products are sold in 72 countries through a network of approximately 2.0 million independent distributors. The company supports the Herbalife Family Foundation and its Casa Herbalife program to help bring good nutrition to children. Herbalife’s Web site contains a significant amount of information about Herbalife, including financial and other information for investors at http://ir.Herbalife.com. The company encourages investors to visit its Web site from time to time, as information is updated and new information is posted.

Disclosure Regarding Forward-Looking Statements


FORWARD-LOOKING STATEMENTS

This document contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws, including any projections of earnings, revenue or other financial items; any statements of the plans, strategies and objectives of management for future operations; any statements concerning proposed new services or developments; any statements regarding future economic conditions or performance; any statements of belief; and any statements of assumptions underlying any of the foregoing. Forward-looking statements may include the words “may,” “will,” “estimate,” “intend,” “continue,” “believe,” “expect” or “anticipate” and any other similar words.

Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, such as those disclosed or incorporated by reference in our filings with the Securities and Exchange Commission. Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in our forward-looking statements include, among others, the following:

our relationship with, and our ability to influence the actions of, our distributors;

adverse publicity associated with our products or network marketing organization;

uncertainties relating to interpretation and enforcement of recently enacted legislation in China governing direct selling;

our inability to obtain the necessary licenses to expand our direct selling business in China;

adverse changes in the Chinese economy, Chinese legal system or Chinese governmental policies;

improper action by our employees or international distributors in violation of applicable law;

changing consumer preferences and demands;

loss or departure of any member of our senior management team which could negatively impact our distributor relations and operating results;

the competitive nature of our business;

regulatory matters governing our products, including potential governmental or regulatory actions concerning the safety or efficacy of our products, and network marketing program including the direct selling market in which we operate;

third party legal challenges to our network marketing program;

risks associated with operating internationally and the effect of economic factors, including foreign exchange, inflation, pricing and currency devaluation risks, especially in countries such as Venezuela;

our dependence on increased penetration of existing markets;

contractual limitations on our ability to expand our business;

our reliance on our information technology infrastructure and outside manufacturers;

the sufficiency of trademarks and other intellectual property rights;

product concentration;

our reliance on our management team;

uncertainties relating to the application of transfer pricing, duties, value added taxes, and other tax regulations, and changes thereto;

changes in tax laws, treaties or regulations, or their interpretation;

taxation relating to our distributors;

product liability claims;

any collateral impact resulting from the ongoing worldwide financial “crisis,” including the availability of liquidity to us, our customers and our suppliers or the willingness of our customers to purchase products in a recessionary economic environment; and

whether we will purchase any of our shares in the open markets or otherwise.

We do not undertake any obligation to update or release any revisions to any forward-looking statement or to report any events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.

1 See Schedule B – “Reconciliation of Non-GAAP Financial Measures” for more detail.
2 Supplemental tables which may include additional business metrics can be found at http://www.ir.Herbalife.com
3 Guidance for first quarter 2010 net sales applying Venezuela 2009 official currency rate would have been 15.5 percent to 16.5 percent.
4 Guidance for fiscal 2010 net sales applying Venezuela 2009 official currency rate would have been 11.0 percent to 13.0 percent.
5 Excludes any accretion/dilution impact should the company elect to utilize any portion of the remaining $226.8 million share repurchase program.


RESULTS OF OPERATIONS:

Herbalife Ltd.
Consolidated Statements of Income
(In thousands, except per share data)
       
           
Quarter Ended Year Ended
  12/31/2009   12/31/2008   12/31/2009   12/31/2008
 
North America $ 126,715 $ 109,277 $ 529,009 $ 496,942
Mexico 69,132 64,205 263,013 352,167
South and Central America 113,223 84,524 366,925 383,590
EMEA 130,932 117,400 504,154 570,703
Asia Pacific 151,468 96,959 509,191 410,789
China   39,401   40,512   152,285   145,022
Worldwide net sales 630,871 512,877 2,324,577 2,359,213
Cost of Sales   136,515   96,061   493,134   458,396
Gross Profit 494,356 416,816 1,831,443 1,900,817
Royalty Overrides 204,580 168,375 761,501 796,718
SGA   205,691   187,573   773,911   771,847
Operating Income 84,085 60,868 296,031 332,252
Interest Expense - net   1,016   2,858   5,103   13,222
Income before income taxes 83,069 58,010 290,928 319,030
Income Taxes   27,413   24,351   87,582   97,840
Net Income   55,656   33,659   203,346   221,190
 
Basic Shares 60,492 62,707 61,221 63,785
Diluted Shares 63,004 63,187 63,097 65,769
 
Basic EPS $ 0.92 $ 0.54 $ 3.32 $ 3.47
Diluted EPS $ 0.88 $ 0.53 $ 3.22 $ 3.36
 
Dividends declared per share $ 0.20 $ 0.20 $ 0.80 $ 0.80
 

Herbalife Ltd.

Consolidated Balance Sheets

(In thousands)

 
Dec 31, Dec 31,
  2009     2008  
 
ASSETS
Current Assets:
Cash & cash equivalents $ 150,801 $ 150,847
Receivables, net 76,958 70,002
Inventories 145,962 134,392
Prepaid expenses and other current assets 101,181 89,214
Deferred income taxes   38,600     40,313  
Total Current Assets 513,502 484,768
 
Property and equipment, net 178,009 175,492
Deferred compensation plan assets 17,410 15,754
Deferred financing cost, net 1,498 1,989
Marketing related intangibles and other intangible assets, net 311,782 310,060
Goodwill 102,543 110,677
Other assets   21,306     22,578  
Total Assets $ 1,146,050   $ 1,121,318  
 
 
LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilities:
Accounts payable $ 37,330 $ 41,084
Royalty Overrides 144,689 130,369
Accrued compensation 65,043 60,629
Accrued expenses 107,943 104,795
Current portion of long term debt 12,402 15,117
Advance sales deposits 22,261 12,603
Income taxes payable   40,298     37,302  
Total Current Liabilities 429,966 401,899
 
Non-current liabilities
Long-term debt, net of current portion 237,931 336,514
Deferred compensation 16,629 13,979
Deferred income taxes 77,613 103,675
Other non-current liabilities   24,600     23,520  
Total Liabilities 786,739 879,587
 
Contingencies
 
Shareholders' equity:
Common shares 120 123
Additional paid in capital 222,882 197,715
Accumulated other comprehensive loss (23,396 ) (28,614 )
Retained earnings   159,705     72,507  
Total Shareholders' Equity   359,311     241,731  
   
Total Liabilities and Shareholders' Equity $ 1,146,050   $ 1,121,318  
 

Herbalife Ltd.

Consolidated Statements of Cash Flows

(In thousands)

       
Year Ended
  12/31/2009       12/31/2008  
 
 
CASH FLOWS FROM OPERATING ACTIVITIES
Net income $ 203,346 $ 221,190
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 62,437 48,732
Excess tax benefits from share-based payment arrangements (3,266 ) (14,602 )
Share based compensation expenses 20,907 17,788
Amortization of discount and deferred financing costs 491 481
Deferred income taxes (11,226 ) (4,103 )
Unrealized foreign exchange transaction loss (gain) 4,809 15,243
Other 340 1,963
Changes in operating assets and liabilities:
Receivables 2,361 (18,529 )
Inventories (1,742 ) (27,572 )
Prepaid expenses and other current assets (7,781 ) (23,966 )
Other assets 2,109 1,800
Accounts payable (9,500 ) 8,922
Royalty overrides 9,102 13,375
Accrued expenses and accrued compensation (3,461 ) 12,412
Advance sales deposits 8,779 1,917
Income taxes payable 4,700 24,191
Deferred compensation plan liability   2,651     (6,254 )
NET CASH PROVIDED BY OPERATING ACTIVITIES   285,056     272,988  
 
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property (59,768 ) (88,601 )
Proceeds from sale of property 102 76
Deferred compensation plan assets (1,656 ) 3,561
Acquisition of business   (10,000 )    
NET CASH USED IN INVESTING ACTIVITIES   (71,322 )   (84,964 )
 
CASH FLOWS FROM FINANCING ACTIVITIES
Dividends paid (48,721 ) (50,700 )
Borrowings from long-term debt 211,974 118,000
Principal payments on long-term debt (313,089 ) (167,481 )
Increase in deferred financing costs - (75 )
Share repurchases (74,641 ) (138,921 )
Excess tax benefits from share-based payment arrangements 3,266 14,602
Proceeds from exercise of stock options and sale of stock under employee stock purchase plan   7,884     19,508  
NET CASH USED IN FINANCING ACTIVITIES   (213,327 )   (205,067 )
EFFECT OF EXCHANGE RATE CHANGES ON CASH   (453 )   (19,517 )
NET CHANGE IN CASH AND CASH EQUIVALENTS (46 ) (36,560 )
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD   150,847     187,407  
CASH AND CASH EQUIVALENTS, END OF PERIOD $ 150,801   $ 150,847  
CASH PAID DURING THE PERIOD
Interest paid $ 10,011   $ 17,735  
Income taxes paid $ 95,139   $ 73,939  
NON CASH ACTIVITIES
Assets acquired under capital leases and other long-term debt $ 388   $ 36,048  
 

Herbalife Ltd
Volume Points by Region
(Unaudited, In thousands)
         
Three Months Ended December 31, Twelve Months Ended December 31,
2009 2008 % Change   2009 2008 % Change  
 
North America 185,340 164,248 12.8 % 779,907 750,437 3.9 %
Mexico 122,395 112,877 8.4 % 493,431 545,900 (9.6 %)
South & Central America 109,236 99,135 10.2 % 411,944 430,612 (4.3 %)
EMEA 115,490 114,791 0.6 % 466,361 497,073 (6.2 %)
Asia Pacific (excluding China) 152,082 113,147 34.4 % 570,673 438,714 30.1 %
China 29,433 31,578 (6.8 %) 115,336 115,895 (0.5 %)
Worldwide 713,976 635,776 12.3 % 2,837,652 2,778,631 2.1 %
 

SUPPLEMENTAL INFORMATION
SCHEDULE A: FINANCIAL GUIDANCE

2010 Guidance

For the Three Months Ending March 31, 2010 and Twelve Months Ending December 31, 2010 1 2 3 4

March 31, 2010   December 31, 2010
Low High Low High
 
Volume point growth vs 2009 3.0 % 4.0 % 5.0 % 6.0 %
Net sales growth vs 2009 12.5 % 13.5 % 8.5 % 9.5 %
EPS $ 0.77 $ 0.80 $ 3.58 $ 3.70
Cap Ex ($ millions) $ 15.0 $ 20.0 $ 65.0 $ 75.0
Effective Tax Rate 30.0 % 31.0 % 30.0 % 31.0 %
 

1 Excludes any accretion/dilution impact should the company elect to utilize any portion of the remaining $226.8 million share repurchase program.
2 Guidance for first quarter 2010 net sales applying Venezuela 2009 official currency rate would have been 15.5 percent - 16.5 percent.
3 Guidance for Fiscal 2010 net sales applying Venezuela 2009 official currency rate would have been 11.0 percent to 13.0 percent.
4  Our 2010 guidance excludes the impact of one-time charges related to highly inflationary accounting for Venezuela.


SCHEDULE B: RECONCILIATION OF NON-GAAP FINANCIAL MEASURES
(Unaudited), (Dollars in Thousands, Except Per Share Data)

In addition to its reported results, the Company has included in the tables below adjusted results that the Securities and Exchange Commission defines as “non-GAAP financial measures.” Management believes that such non-GAAP financial measures, when read in conjunction with the Company’s reported results, can provide useful supplemental information for investors analyzing period to period comparisons of the Company’s results.

The following is a reconciliation of net income, presented and reported in accordance with U.S. generally accepted accounting principles, to net income adjusted for certain items:

Three Months Ended   Twelve Months Ended
  12/31/2009     12/31/2008   12/31/2009     12/31/2008
Net income, as reported $ 55,656 $ 33,659 $ 203,346 $ 221,190
Restructuring Expenses associated with realignment for growth initiative (1) (2) - 3,636 899 4,769
Venezuela impact (3) 6,615 - 6,615 -
Expiration of statutes of limitations - - (4,852 ) -
Increase in tax valuation allowance on deferred tax assets - 6,097 - 6,097
Tax expense resulting from an international income tax audit settlement   (537 )   -   1,091     -
Net income, as adjusted $ 61,734   $ 43,392 $ 207,099   $ 232,056
 

The following is a reconciliation of diluted earnings per share, presented and reported in accordance with U.S. generally accepted accounting principles, to diluted earnings per share adjusted for certain items:

Three Months Ended   Twelve Months Ended
  12/31/2009     12/31/2008   12/31/2009     12/31/2008
Diluted earnings per share, as reported $ 0.88 $ 0.53 $ 3.22 $ 3.36
Restructuring Expenses associated with realignment for growth initiative (1) (4) - 0.06 0.01 0.07
Venezuela impact (5) 0.11 - 0.11 -
Expiration of statutes of limitations - - (0.08 ) -
Increase in tax valuation allowance on deferred tax assets - 0.10 - 0.09
Tax expense resulting from an international income tax audit settlement   (0.01 )   -   0.02     -
Diluted earnings per share, as adjusted (6) $ 0.98   $ 0.69   $ 3.28   $ 3.53
 

The following is a reconciliation of total long-term debt to net debt:

  12/31/2009     12/31/2008
 
Total long-term debt (current and long-term portion) $ 250,333 $ 351,631
Less: Cash and cash equivalents   150,801   150,847
Net debt $ 99,532   $ 200,784
 
(1)   The restructuring charge adjustments reflect items that although they, or similar items, might recur are of a nature and magnitude that identifying them separately provides investors with a greater ability to project the Company’s future performance.
(2) Net of tax benefit of $1,197, $399 and $1,931 for the three months ended December 31, 2008, twelve months ended December 31, 2009 and 2008, respectively.
(3) Net of tax benefit of $3,561 for the three and twelve months ended December 31, 2009.
(4) Net of tax benefit of $0.02, $0.01 and $0.03 per common diluted share for the three months ended December 31, 2008, twelve months ended December 31, 2009 and 2008, respectively.
(5) Net of tax benefit of $0.06 per common diluted share for the three and twelve months ended December 31, 2009.
(6) Amounts may not total due to rounding.

CONTACT:
Herbalife Ltd.
Media Contact:
Barbara Henderson
SVP, Worldwide Corp. Comm.
(213) 745-0517
or
Investor Contact:
Amy Greene
VP, Investor Relations
(213) 745-0474